SCHEMBL703919

SCHEMBL703919

CC(O)[PH2]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8615710 0.70 — —
SCHEMBL4308005 0.70 — —
SCHEMBL7252042 0.67 — —
SCHEMBL51846 0.64 — —
SCHEMBL314229 0.64 — —
Isopropyl Alcohol SCHEMBL16914724 0.61 — —
Isopropyl Alcohol SCHEMBL29500440 0.61 — —
Isopropyl Alcohol SCHEMBL385 0.61 — —
Isopropyl Alcohol SCHEMBL29814955 0.61 — —
Isopropyl Alcohol SCHEMBL890876 0.61 ALDH1A1 (1.00) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021199003-A1 OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF INFLAMMATION OR INFECTIOUS DISEASE CAUSED BY CORONAVIRUS INFECTION VASCULAR BIOGENICS LTD. (IL) 2021-10-07 — — WO claimed
US-10716800-B2 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2020-07-21 — — US claimed
US-20190040150-A1 Motile Sperm Domain Containing Protein 2 and Cancer IMMUNEWALK THERAPEUTICS, INC. 2019-02-07 — — US claimed
US-20180214543-A1 Motile Sperm Domain Containing Protein 2 and Inflammation IMMUNEWALK THERAPEUTICS, INC. 2018-08-02 — — US claimed
CN-108135933-A Protein 2 and cancer containing motile sperm structural domain 脉管生物生长有限公司 2018-06-08 — — CN claimed
EP-3328401-A1 MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND CANCER Vascular Biogenics Ltd. (IL) 2018-06-06 — — EP claimed
EP-3328408-A2 MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND INFLAMMATION Vascular Biogenics Ltd. (IL) 2018-06-06 — — EP claimed
CN-107921084-A Protein 2 and inflammation containing motile sperm domain 脉管生物生长有限公司 2018-04-17 — — CN claimed
EP-3223824-A1 OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF FIBROSIS Vascular Biogenics Ltd. (IL) 2017-10-04 — — EP claimed
WO-2017021855-A2 MOTILE SPERM DOMAIN CONTAINING PROTEIN 2 AND INFLAMMATION VASCULAR BIOGENICS LTD. (IL) 2017-02-09 — — WO claimed
EP-1626728-A4 OXIDIZED LIPIDS AND USES THEREOF IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS VASCULAR BIOGENICS LTD (IL) 2009-09-02 — — EP claimed
WO-2009050692-A2 PLATELET-ACTIVATING FACTOR (PAF) ANALOGS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2009-04-23 — — WO claimed
US-20080261865-A1 Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders VASCULAR BIOGENICS LTD. (IL) 2008-10-23 — — US claimed
WO-2008084472-A2 IMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS VASCULAR BIOGENICS LTD. (IL) 2008-07-17 — — WO claimed
US-20070112211-A1 Process for the preparation of oxidized phospholipids VASCULAR BIOGENICS LTD. (IL) 2007-05-17 — — US claimed
US-20070099868-A1 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders VASCULAR BIOGENICS LTD. (IL) 2007-05-03 — — US claimed
EP-1773352-A2 IMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS Vascular Biogenics Ltd. (IL) 2007-04-18 — — EP claimed
EP-1626728-A2 OXIDIZED LIPIDS AND USES THEREOF IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS Vascular Biogenics Ltd. (IL) 2006-02-22 — — EP claimed
WO-2006006161-A2 IMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS VASCULAR BIOGENICS LTD. (IL) 2006-01-19 — — WO claimed
WO-2004106486-A2 OXIDIZED LIPIDS AND USES THEREOF IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS VASCULAR BIOGENICS LTD. (IL) 2004-12-09 — — WO claimed
Send feedback